Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Mondragón L[au]:

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Routy B et al. Science. (2018)

Anticancer effects of anti-CD47 immunotherapy <i>in vivo</i>. Iribarren K et al. Oncoimmunology. (2019)

Low-Protein Diet Induces IRE1α-Dependent Anticancer Immunosurveillance. Rubio-Patiño C et al. Cell Metab. (2018)

Search results

Items: 1 to 50 of 70

1.

Data of synthesis, characterization and luminescence measurements in 1D lanthanide coordination polymers based on lanthanides.

D'Vries RF, Gomez GE, Mondragon LP, Onna D, Barja BC, Soler-Illia GJAA, Ellena J.

Data Brief. 2019 Oct 22;27:104709. doi: 10.1016/j.dib.2019.104709. eCollection 2019 Dec.

2.

Planning and managing a complex multisite study in the age of technology.

Miller CW, Greenawalt JA, Kardong-Edgren SS, Oermann MH, Molloy M, Mudra V, Rogers N, Mondragon L, Cespedes A, Frost E, Causey R, Webb S, Muñana A, Chen A.

Nurs Forum. 2019 Oct;54(4):707-713. doi: 10.1111/nuf.12401. Epub 2019 Oct 30.

PMID:
31667848
3.

GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism.

Mondragón L, Mhaidly R, De Donatis GM, Tosolini M, Dao P, Martin AR, Pons C, Chiche J, Jacquin M, Imbert V, Proïcs E, Boyer L, Doye A, Luciano F, Neels JG, Coutant F, Fabien N, Sormani L, Rubio-Patiño C, Bossowski JP, Muller F, Marchetti S, Villa E, Peyron JF, Gaulard P, Lemonnier F, Asnafi V, Genestier L, Benhida R, Fournié JJ, Passeron T, Ricci JE, Verhoeyen E.

Cancer Cell. 2019 Sep 16;36(3):268-287.e10. doi: 10.1016/j.ccell.2019.07.008. Epub 2019 Aug 22.

PMID:
31447347
4.

Tumor lysis with LTX-401 creates anticancer immunity.

Xie W, Mondragón L, Mauseth B, Wang Y, Pol J, Lévesque S, Zhou H, Yamazaki T, Eksteen JJ, Zitvogel L, Sveinbjørnsson B, Rekdal Ø, Kepp O, Kroemer G.

Oncoimmunology. 2019 Apr 13;8(7):1594555. doi: 10.1080/2162402X.2019.1594555. eCollection 2019.

PMID:
31143516
5.

AIF-regulated oxidative phosphorylation supports lung cancer development.

Rao S, Mondragón L, Pranjic B, Hanada T, Stoll G, Köcher T, Zhang P, Jais A, Lercher A, Bergthaler A, Schramek D, Haigh K, Sica V, Leduc M, Modjtahedi N, Pai TP, Onji M, Uribesalgo I, Hanada R, Kozieradzki I, Koglgruber R, Cronin SJ, She Z, Quehenberger F, Popper H, Kenner L, Haigh JJ, Kepp O, Rak M, Cai K, Kroemer G, Penninger JM.

Cell Res. 2019 Jul;29(7):579-591. doi: 10.1038/s41422-019-0181-4. Epub 2019 May 27.

6.

Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate.

Sica V, Bravo-San Pedro JM, Izzo V, Pol J, Pierredon S, Enot D, Durand S, Bossut N, Chery A, Souquere S, Pierron G, Vartholomaiou E, Zamzami N, Soussi T, Sauvat A, Mondragón L, Kepp O, Galluzzi L, Martinou JC, Hess-Stumpp H, Ziegelbauer K, Kroemer G, Maiuri MC.

Cell Rep. 2019 Apr 16;27(3):820-834.e9. doi: 10.1016/j.celrep.2019.03.058.

7.

Anticancer effects of anti-CD47 immunotherapy in vivo.

Iribarren K, Buque A, Mondragon L, Xie W, Lévesque S, Pol J, Zitvogel L, Kepp O, Kroemer G.

Oncoimmunology. 2018 Dec 11;8(3):1550619. doi: 10.1080/2162402X.2018.1550619. eCollection 2019.

8.

Caspase 1/11 Deficiency or Pharmacological Inhibition Mitigates Psoriasis-Like Phenotype in Mice.

Aira LE, Gonçalves D, Bossowski JP, Rubio-Patiño C, Chiche J, Paul-Bellon R, Mondragón L, Gesson M, Lecucq-Ottavi P, Obba S, Colosetti P, Luciano F, Bailly-Maitre B, Boyer L, Jacquel A, Robert G, Ricci JE, Ortonne JP, Passeron T, Lacour JP, Auberger P, Marchetti S.

J Invest Dermatol. 2019 Jun;139(6):1306-1317. doi: 10.1016/j.jid.2018.11.031. Epub 2018 Dec 17.

PMID:
30571969
9.

Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals.

Zhou H, Mondragón L, Xie W, Mauseth B, Leduc M, Sauvat A, Gomes-da-Silva LC, Forveille S, Iribarren K, Souquere S, Bezu L, Liu P, Zhao L, Zitvogel L, Sveinbjørnsson B, Eksteen JJ, Rekdal Ø, Kepp O, Kroemer G.

Cell Death Dis. 2018 Oct 23;9(11):1086. doi: 10.1038/s41419-018-1127-3.

10.

Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus.

Gomes-da-Silva LC, Zhao L, Bezu L, Zhou H, Sauvat A, Liu P, Durand S, Leduc M, Souquere S, Loos F, Mondragón L, Sveinbjørnsson B, Rekdal Ø, Boncompain G, Perez F, Arnaut LG, Kepp O, Kroemer G.

EMBO J. 2018 Jul 2;37(13). pii: e98354. doi: 10.15252/embj.201798354. Epub 2018 May 28.

11.

Low-Protein Diet Induces IRE1α-Dependent Anticancer Immunosurveillance.

Rubio-Patiño C, Bossowski JP, De Donatis GM, Mondragón L, Villa E, Aira LE, Chiche J, Mhaidly R, Lebeaupin C, Marchetti S, Voutetakis K, Chatziioannou A, Castelli FA, Lamourette P, Chu-Van E, Fenaille F, Avril T, Passeron T, Patterson JB, Verhoeyen E, Bailly-Maitre B, Chevet E, Ricci JE.

Cell Metab. 2018 Apr 3;27(4):828-842.e7. doi: 10.1016/j.cmet.2018.02.009.

12.

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L.

Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.

PMID:
29097494
13.

Parkin-Independent Mitophagy Controls Chemotherapeutic Response in Cancer Cells.

Villa E, Proïcs E, Rubio-Patiño C, Obba S, Zunino B, Bossowski JP, Rozier RM, Chiche J, Mondragón L, Riley JS, Marchetti S, Verhoeyen E, Tait SWG, Ricci JE.

Cell Rep. 2017 Sep 19;20(12):2846-2859. doi: 10.1016/j.celrep.2017.08.087.

14.

Camera-based assessment of arterial stiffness and wave reflection parameters from neck micro-motion.

Moço AV, Mondragon LZ, Wang W, Stuijk S, de Haan G.

Physiol Meas. 2017 Jul 28;38(8):1576-1598. doi: 10.1088/1361-6579/aa7d43.

PMID:
28671872
15.

Immunosuppressive γδ T cells foster pancreatic carcinogenesis.

Mondragón L, Kroemer G, Galluzzi L.

Oncoimmunology. 2016 Sep 27;5(11):e1237328. doi: 10.1080/2162402X.2016.1237328. eCollection 2016. No abstract available.

16.

Low carbohydrate diet prevents Mcl-1-mediated resistance to BH3-mimetics.

Rubio-Patiño C, Bossowski JP, Villa E, Mondragón L, Zunino B, Proïcs E, Chiche J, Bost F, Verhoeyen E, Ricci JE.

Oncotarget. 2016 Nov 8;7(45):73270-73279. doi: 10.18632/oncotarget.12309.

17.

Caspase 3 Targeted Cargo Delivery in Apoptotic Cells Using Capped Mesoporous Silica Nanoparticles.

de la Torre C, Mondragón L, Coll C, García-Fernández A, Sancenón F, Martínez-Máñez R, Amorós P, Pérez-Payá E, Orzáez M.

Chemistry. 2015 Oct 26;21(44):15506-10. doi: 10.1002/chem.201502413. Epub 2015 Sep 10.

PMID:
26493876
18.

Apaf1 inhibition promotes cell recovery from apoptosis.

Gortat A, Sancho M, Mondragón L, Messeguer À, Pérez-Payá E, Orzáez M.

Protein Cell. 2015 Nov;6(11):833-43. doi: 10.1007/s13238-015-0200-2. Epub 2015 Sep 11.

19.

Drug Delivery Strategies of Chemical CDK Inhibitors.

Alvira D, Mondragón L.

Methods Mol Biol. 2016;1336:141-54. doi: 10.1007/978-1-4939-2926-9_12.

PMID:
26231714
20.

Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90.

Zunino B, Rubio-Patiño C, Villa E, Meynet O, Proics E, Cornille A, Pommier S, Mondragón L, Chiche J, Bereder JM, Carles M, Ricci JE.

Oncogene. 2016 Jan 14;35(2):261-8. doi: 10.1038/onc.2015.82. Epub 2015 Apr 13.

PMID:
25867070
21.

GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α.

Chiche J, Pommier S, Beneteau M, Mondragón L, Meynet O, Zunino B, Mouchotte A, Verhoeyen E, Guyot M, Pagès G, Mounier N, Imbert V, Colosetti P, Goncalvès D, Marchetti S, Brière J, Carles M, Thieblemont C, Ricci JE.

Leukemia. 2015 May;29(5):1163-76. doi: 10.1038/leu.2014.324. Epub 2014 Nov 14.

PMID:
25394713
22.

Apaf-1 inhibitors protect from unwanted cell death in in vivo models of kidney ischemia and chemotherapy induced ototoxicity.

Orzáez M, Sancho M, Marchán S, Mondragón L, Montava R, Valero JG, Landeta O, Basañez G, Carbajo RJ, Pineda-Lucena A, Bujons J, Moure A, Messeguer A, Lagunas C, Herrero C, Pérez-Payá E.

PLoS One. 2014 Oct 20;9(10):e110979. doi: 10.1371/journal.pone.0110979. eCollection 2014.

23.

Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles.

de la Torre C, Mondragón L, Coll C, Sancenón F, Marcos MD, Martínez-Máñez R, Amorós P, Pérez-Payá E, Orzáez M.

Chemistry. 2014 Nov 17;20(47):15309-14. doi: 10.1002/chem.201404382. Epub 2014 Oct 10.

PMID:
25303093
24.

Enhanced antifungal efficacy of tebuconazole using gated pH-driven mesoporous nanoparticles.

Mas N, Galiana I, Hurtado S, Mondragón L, Bernardos A, Sancenón F, Marcos MD, Amorós P, Abril-Utrillas N, Martínez-Máñez R, Murguía JR.

Int J Nanomedicine. 2014 May 23;9:2597-606. doi: 10.2147/IJN.S59654. eCollection 2014.

25.

Enzyme-responsive intracellular-controlled release using silica mesoporous nanoparticles capped with ε-poly-L-lysine.

Mondragón L, Mas N, Ferragud V, de la Torre C, Agostini A, Martínez-Máñez R, Sancenón F, Amorós P, Pérez-Payá E, Orzáez M.

Chemistry. 2014 Apr 25;20(18):5271-81. doi: 10.1002/chem.201400148. Epub 2014 Apr 2.

PMID:
24700694
26.

Temperature-controlled release by changes in the secondary structure of peptides anchored onto mesoporous silica supports.

de la Torre C, Agostini A, Mondragón L, Orzáez M, Sancenón F, Martínez-Máñez R, Marcos MD, Amorós P, Pérez-Payá E.

Chem Commun (Camb). 2014 Mar 25;50(24):3184-6. doi: 10.1039/c3cc49421g. Epub 2014 Feb 12.

PMID:
24519805
27.

Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in mice.

Meynet O, Zunino B, Happo L, Pradelli LA, Chiche J, Jacquin MA, Mondragón L, Tanti JF, Taillan B, Garnier G, Reverso-Meinietti J, Mounier N, Michiels JF, Michalak EM, Carles M, Scott CL, Ricci JE.

Blood. 2013 Oct 3;122(14):2402-11. doi: 10.1182/blood-2013-01-478651. Epub 2013 Aug 21.

PMID:
23966420
28.

Selective, highly sensitive, and rapid detection of genomic DNA by using gated materials: Mycoplasma detection.

Climent E, Mondragón L, Martínez-Máñez R, Sancenón F, Marcos MD, Murguía JR, Amorós P, Rurack K, Pérez-Payá E.

Angew Chem Int Ed Engl. 2013 Aug 19;52(34):8938-42. doi: 10.1002/anie.201302954. Epub 2013 Jul 10. No abstract available.

PMID:
23843346
29.

Enhanced efficacy and broadening of antibacterial action of drugs via the use of capped mesoporous nanoparticles.

Mas N, Galiana I, Mondragón L, Aznar E, Climent E, Cabedo N, Sancenón F, Murguía JR, Martínez-Máñez R, Marcos MD, Amorós P.

Chemistry. 2013 Aug 19;19(34):11167-71. doi: 10.1002/chem.201302170. Epub 2013 Jul 9.

PMID:
23839913
30.

Enzyme-responsive silica mesoporous supports capped with azopyridinium salts for controlled delivery applications.

Mas N, Agostini A, Mondragón L, Bernardos A, Sancenón F, Marcos MD, Martínez-Máñez R, Costero AM, Gil S, Merino-Sanjuán M, Amorós P, Orzáez M, Pérez-Payá E.

Chemistry. 2013 Jan 21;19(4):1346-56. doi: 10.1002/chem.201202740. Epub 2012 Dec 7.

PMID:
23225567
31.

Amidase-responsive controlled release of antitumoral drug into intracellular media using gluconamide-capped mesoporous silica nanoparticles.

Candel I, Aznar E, Mondragón L, de la Torre C, Martínez-Máñez R, Sancenón F, Marcos MD, Amorós P, Guillem C, Pérez-Payá E, Costero A, Gil S, Parra M.

Nanoscale. 2012 Nov 21;4(22):7237-45. doi: 10.1039/c2nr32062b.

PMID:
23072883
32.

Design of enzyme-mediated controlled release systems based on silica mesoporous supports capped with ester-glycol groups.

Agostini A, Mondragón L, Pascual L, Aznar E, Coll C, Martínez-Máñez R, Sancenón F, Soto J, Marcos MD, Amorós P, Costero AM, Parra M, Gil S.

Langmuir. 2012 Oct 16;28(41):14766-76. doi: 10.1021/la303161e. Epub 2012 Oct 3.

PMID:
22998170
33.

Targeted cargo delivery in senescent cells using capped mesoporous silica nanoparticles.

Agostini A, Mondragón L, Bernardos A, Martínez-Máñez R, Marcos MD, Sancenón F, Soto J, Costero A, Manguan-García C, Perona R, Moreno-Torres M, Aparicio-Sanchis R, Murguía JR.

Angew Chem Int Ed Engl. 2012 Oct 15;51(42):10556-60. doi: 10.1002/anie.201204663. Epub 2012 Sep 20.

PMID:
22996839
34.

Azobenzene polyesters used as gate-like scaffolds in nanoscopic hybrid systems.

Bernardos A, Mondragón L, Javakhishvili I, Mas N, de la Torre C, Martínez-Máñez R, Sancenón F, Barat JM, Hvilsted S, Orzaez M, Pérez-Payá E, Amorós P.

Chemistry. 2012 Oct 8;18(41):13068-78. doi: 10.1002/chem.201200787. Epub 2012 Aug 24.

PMID:
22927363
35.

Dual enzyme-triggered controlled release on capped nanometric silica mesoporous supports.

Agostini A, Mondragón L, Coll C, Aznar E, Marcos MD, Martínez-Máñez R, Sancenón F, Soto J, Pérez-Payá E, Amorós P.

ChemistryOpen. 2012 Feb;1(1):17-20. doi: 10.1002/open.201200003. Epub 2012 Feb 17. No abstract available.

36.

Finely tuned temperature-controlled cargo release using paraffin-capped mesoporous silica nanoparticles.

Aznar E, Mondragón L, Ros-Lis JV, Sancenón F, Marcos MD, Martínez-Máñez R, Soto J, Pérez-Payá E, Amorós P.

Angew Chem Int Ed Engl. 2011 Nov 18;50(47):11172-5. doi: 10.1002/anie.201102756. Epub 2011 Sep 27. No abstract available.

PMID:
21953879
37.

Enzyme-mediated controlled release systems by anchoring peptide sequences on mesoporous silica supports.

Coll C, Mondragón L, Martínez-Máñez R, Sancenón F, Marcos MD, Soto J, Amorós P, Pérez-Payá E.

Angew Chem Int Ed Engl. 2011 Feb 25;50(9):2138-40. doi: 10.1002/anie.201004133. Epub 2011 Feb 1. No abstract available.

PMID:
21344569
38.

Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".

Bernardos A, Mondragon L, Aznar E, Marcos MD, Martinez-Mañez R, Sancenon F, Soto J, Barat JM, Perez-Paya E, Guillem C, Amoros P.

ACS Nano. 2010 Nov 23;4(11):6353-68. doi: 10.1021/nn101499d. Epub 2010 Oct 19.

PMID:
20958020
39.

DISYUNTIVAS EN LAS CONCEPCIONES SOBRE AUTONOMÍA Y BENEFICENCIA QUE AFECTAN LA TERAPÉUTICA DEL INTENTO SUICIDA.

Mondragón L, Monroy Z, Ito ME, Medina-Mora DM.

Acta Bioeth. 2010 Jun;16(1):77-86.

40.

Molecules that modulate Apaf-1 activity.

Pérez-Payá E, Orzáez M, Mondragón L, Wolan D, Wells JA, Messeguer A, Vicent MJ.

Med Res Rev. 2011 Jul;31(4):649-75. doi: 10.1002/med.20198. Epub 2010 Jan 22. Review.

PMID:
20099266
41.

Deciphering the antitumoral activity of quinacrine: Binding to and inhibition of Bcl-xL.

Orzáez M, Mondragón L, García-Jareño A, Mosulén S, Pineda-Lucena A, Pérez-Payá E.

Bioorg Med Chem Lett. 2009 Mar 15;19(6):1592-5. doi: 10.1016/j.bmcl.2009.02.020. Epub 2009 Feb 8.

PMID:
19237284
42.

A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint.

Mondragón L, Galluzzi L, Mouhamad S, Orzáez M, Vicencio JM, Vitale I, Moure A, Messeguer A, Perez-Paya E, Kroemer G.

Apoptosis. 2009 Feb;14(2):182-90. doi: 10.1007/s10495-008-0310-x.

PMID:
19152031
43.

ATP-noncompetitive inhibitors of CDK-cyclin complexes.

Orzáez M, Gortat A, Mondragón L, Bachs O, Pérez-Payá E.

ChemMedChem. 2009 Jan;4(1):19-24. doi: 10.1002/cmdc.200800185. Review.

PMID:
19039815
44.

Peptides and peptide mimics as modulators of apoptotic pathways.

Orzáez M, Gortat A, Mondragón L, Pérez-Payá E.

ChemMedChem. 2009 Feb;4(2):146-60. doi: 10.1002/cmdc.200800246. Review.

PMID:
19021159
45.

Ethnography in an emergency room: evaluating patients with alcohol consumption.

Mondragón L, Romero M, Borges G.

Salud Publica Mex. 2008 Jul-Aug;50(4):308-15.

PMID:
18670722
46.

Conformationally restricted hydantoin-based peptidomimetics as inhibitors of caspase-3 with basic groups allowed at the S3 enzyme subsite.

Vázquez J, García-Jareño A, Mondragón L, Rubio-Martinez J, Pérez-Payá E, Albericio F.

ChemMedChem. 2008 Jun;3(6):979-85. doi: 10.1002/cmdc.200800020.

PMID:
18393268
47.

Modulation of cellular apoptosis with apoptotic protease-activating factor 1 (Apaf-1) inhibitors.

Mondragón L, Orzáez M, Sanclimens G, Moure A, Armiñán A, Sepúlveda P, Messeguer A, Vicent MJ, Pérez-Payá E.

J Med Chem. 2008 Feb 14;51(3):521-9. doi: 10.1021/jm701195j. Epub 2008 Jan 16.

PMID:
18197610
48.

Conjugation of a novel Apaf-1 inhibitor to peptide-based cell-membrane transporters: effective methods to improve inhibition of mitochondria-mediated apoptosis.

Orzáez M, Mondragón L, Marzo I, Sanclimens G, Messeguer A, Pérez-Payá E, Vicent MJ.

Peptides. 2007 May;28(5):958-68. Epub 2007 Mar 3.

49.

A case-control study of alcohol and substance use disorders as risk factors for non-fatal injury.

Borges G, Mondragón L, Medina-Mora ME, Orozco R, Zambrano J, Cherpitel C.

Alcohol Alcohol. 2005 Jul-Aug;40(4):257-62. Epub 2005 Apr 25.

PMID:
15851400
50.

A psycho-educational intervention for depressed women: a qualitative analysis of the process.

Lara MA, Navarro C, Acevedo M, Berenzon S, Mondragón L, Rubí NA.

Psychol Psychother. 2004 Dec;77(Pt 4):429-47.

PMID:
15588453

Supplemental Content

Loading ...
Support Center